Physician profile
John L Walters
NPI 1689670762
$769.76
in general payments reported to CMS, 2019-2025
12 companies · $23.27 in 2025
The $23.27 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $13.58 · 2021: $39.89 · 2022: $217 · 2023: $182 · 2024: $164 · 2025: $23.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $240.74 | 2022-2024 | Lumigan, Vuity, Alphagan P |
| Hoffmann-La Roche Limited | $104.82 | 2019 | |
| Oyster Point Pharma, INC. | $86.30 | 2023-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $74.82 | 2024 | Vyzulta, Miebo, Infuse |
| Alcon Vision LLC | $52.18 | 2022-2024 | Rocklatan, Total30 |
| Coopervision INC. | $44.71 | 2021-2023 | Myday Contact Lens |
| Novartis Pharmaceuticals Corporation | $42.10 | 2023 | |
| Allergan, INC. | $31.65 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $24.59 | 2022 | |
| Rxsight INC | $23.27 | 2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Sun Pharmaceutical Industries INC. | $19.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.